AU5609998A - Tablet for the controlled release of active agents - Google Patents

Tablet for the controlled release of active agents

Info

Publication number
AU5609998A
AU5609998A AU56099/98A AU5609998A AU5609998A AU 5609998 A AU5609998 A AU 5609998A AU 56099/98 A AU56099/98 A AU 56099/98A AU 5609998 A AU5609998 A AU 5609998A AU 5609998 A AU5609998 A AU 5609998A
Authority
AU
Australia
Prior art keywords
tablet
active agents
controlled release
agents
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56099/98A
Other languages
English (en)
Inventor
Kolette M. Flood
Sharon L. Graham
Steven L. Krill
Yihong Qiu
Jay S. Trivedi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU5609998A publication Critical patent/AU5609998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU56099/98A 1997-01-10 1997-12-18 Tablet for the controlled release of active agents Abandoned AU5609998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78176197A 1997-01-10 1997-01-10
US08781761 1997-01-10
PCT/US1997/023358 WO1998030208A1 (en) 1997-01-10 1997-12-18 Tablet for the controlled release of active agents

Publications (1)

Publication Number Publication Date
AU5609998A true AU5609998A (en) 1998-08-03

Family

ID=25123834

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56099/98A Abandoned AU5609998A (en) 1997-01-10 1997-12-18 Tablet for the controlled release of active agents

Country Status (8)

Country Link
US (1) US6033685A (enExample)
EP (1) EP0951279A1 (enExample)
JP (1) JP5170723B2 (enExample)
AR (1) AR010875A1 (enExample)
AU (1) AU5609998A (enExample)
CA (1) CA2277220A1 (enExample)
WO (1) WO1998030208A1 (enExample)
ZA (1) ZA9880B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
GB9901688D0 (en) * 1999-01-26 1999-03-17 Unilever Plc Detergent compositions
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6960357B2 (en) * 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2409552A1 (en) * 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
EP1455751A1 (en) * 2001-12-20 2004-09-15 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
CA2507042A1 (en) * 2002-12-06 2004-06-24 Ucb Farchim, S.A. Tablet comprising efletirizine and pseudoephedrine
US20040228830A1 (en) * 2003-01-28 2004-11-18 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
EP1599189A4 (en) * 2003-03-04 2009-07-01 Nostrum Pharmaceuticals Inc FORMULATION WITH CONTROLLED RELEASE AND WITH WATER-REPELLENT MATERIAL AS A MEANS FOR DELAYED RELEASE
SI1575565T1 (sl) * 2003-08-08 2010-04-30 Biovail Lab Int Srl Tableta bupropion hidroklorida z modificiranim sprošŽŤanjem
EP1715856B1 (en) * 2003-12-31 2012-07-11 Actavis Group PTC ehf. Atomoxetine formulations
EP1781262A1 (en) * 2004-07-29 2007-05-09 Sanofi-Aventis Pharmaceutical multilayer tablet for controlled_release of active ingredients with highly ph-dependent solubility
US20080248107A1 (en) * 2005-08-24 2008-10-09 Rubicon Research Pvt. Ltd. Controlled Release Formulation
US8691272B2 (en) 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
JP4953673B2 (ja) * 2006-03-22 2012-06-13 リンテック株式会社 経口投与剤
US20080107725A1 (en) * 2006-10-13 2008-05-08 Albano Antonio A Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
KR100885029B1 (ko) * 2007-02-07 2009-02-23 지엘팜텍 주식회사 경구투여용 서방성 삼중정제
KR20100136967A (ko) * 2008-02-15 2010-12-29 썬 파마 어드밴스트 리서치 컴패니 리미티드 파열 효과가 감소된 방출 제어 경구 정제
US20100260842A1 (en) * 2009-04-06 2010-10-14 Rashmi Nair Pseudoephedrine pharmaceutical formulations
CA2775091A1 (en) * 2009-08-05 2011-02-10 Lupin Limited Controlled release pharmaceutical compositions of milnacipran
US9572909B2 (en) * 2009-09-14 2017-02-21 Virginia Commonwealth University Electrospun nerve guides for nerve regeneration designed to modulate nerve architecture
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10485770B2 (en) 2009-12-21 2019-11-26 Aptapharma, Inc. Functionally-coated multilayer tablets
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
MX394356B (es) 2016-01-20 2025-03-24 Theravida Inc Métodos y composiciones para tratar hiperhidrosis.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564759A (enExample) * 1955-12-22
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
ES2037179T3 (es) * 1987-11-25 1993-06-16 American Cyanamid Company Sistema de liberacion sostenida (controlada) para bloqueadores de canales de calcio de dihidropiridina.
JPH04360826A (ja) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk 放出制御製剤
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
US5593694A (en) * 1991-10-04 1997-01-14 Yoshitomi Pharmaceutical Industries, Ltd. Sustained release tablet
JPH0791500B2 (ja) * 1991-10-25 1995-10-04 太田インキ製造株式会社 印刷インキ組成物
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
IT1265240B1 (it) * 1993-11-30 1996-10-31 Ekita Investments Nv Compressa farmaceutica a rilascio controllato, di forma lenticolare
CA2136810A1 (en) * 1994-06-30 1995-12-31 Franklin M. C. Chen Absorbent structure including an adhesive

Also Published As

Publication number Publication date
CA2277220A1 (en) 1998-07-16
EP0951279A1 (en) 1999-10-27
JP5170723B2 (ja) 2013-03-27
AR010875A1 (es) 2000-07-12
WO1998030208A1 (en) 1998-07-16
US6033685A (en) 2000-03-07
ZA9880B (en) 1998-07-08
JP2001508440A (ja) 2001-06-26

Similar Documents

Publication Publication Date Title
AU5609998A (en) Tablet for the controlled release of active agents
AU3406497A (en) Controlled release tablet
ZA9811799B (en) Solid galenic form of the controlled release tablet type for the instant and then prolonged release of one or more active substances
AU1690399A (en) Neovascularization inhibitor containing dienogest as the active ingredient
AU2886799A (en) Monolithic tablet for controlled drug release
IL134084A0 (en) Biodegradable macromers for the controlled release of biologically active substances
AU5387898A (en) Pharmaceutical agents
AU8676698A (en) Devices for providing therapeutic substances
AU7672798A (en) Controlled release chemicals
AU5171196A (en) Controlled release tablet
AU6086398A (en) Image-directed active range finding system
ZA988718B (en) Drug formulation having controlled release of active compound
GB9519094D0 (en) Granulated active with controlled release
AU4515996A (en) Methods for increasing the bioavailability of biological active agents
AU6386801A (en) System for the release of active ingredients
HUP0002719A3 (en) Controlled release pharmaceutical preparation with ace inhibitor as active agent
AU2080199A (en) New pharmaceutically active compounds
HUP9901715A3 (en) Layered tablet for the controlled release of active substances
AU2448895A (en) Device for the release of an active agent
AU2773597A (en) Pharmaceutical compositions for the sustained release of insoluble active principles
AU5820900A (en) Capsule for the controlled release of active substances
AU8532798A (en) Compounds which delay the release of active substances
AU1786799A (en) Composition for the controlled release of active compounds
AU6220798A (en) Release agent
AU1171099A (en) Therapeutic agents